Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Onco-Innovations Ltd. ( (TSE:ONCO) ) is now available.
Onco-Innovations Limited announced a non-brokered private placement to raise up to $2 million through the issuance of units comprising common shares and warrants. The funds will support the company’s operational and R&D objectives. Additionally, the company appointed Mr. Christopher Gulka to its Board of Directors, bringing extensive experience in capital and public markets, which could enhance Onco-Innovations’ strategic positioning in the industry.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company specializing in oncology, focusing on cancer research and treatment. The company is dedicated to pioneering research and innovative solutions for the prevention and treatment of cancer, and it holds an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 41,446
Technical Sentiment Signal: Strong Sell
For a thorough assessment of ONCO stock, go to TipRanks’ Stock Analysis page.